Sigma Healthcare (ASX:SIG) reports NPAT up 133.6%

Company News

by Rachael Jones

Sigma Healthcare (ASX:SIG) report NPAT up 133.6 per cent to $29.1 million.

Reported EBITDA of $94.2 million for FY21, up 289.2 per cent on the prior year, with Underlying EBITDA of $81.1 million up 39.2 per cent, which is slightly ahead of the guidance provided on 8 February 2021.

Sigma CEO and Managing Director Mark Hooper commented: “This is a milestone result.

The Board has declared a dividend of one cent per share fully franked.

Shares in Sigma Healthcare (ASX:SIG) are trading 3.4 per cent higher at 69 cents.
  

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.